Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Breast Care (Basel, Switzerland)
|
January 27, 2022
Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer Patients
Christoph Suppan, Daniel Steiner, Eva Valentina Klocker, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 15, 2024
Functional limitations 3 and 12 months after venous thromboembolism: a cohort study
Daniel Steiner, Stephan Nopp, Georg Heinze, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 1, 2024
Neoadjuvant therapy in early-stage non-small cell lung cancer: A real-world analysis
Leyla Ay, Daniel Steiner, Hannah Fabikan, et al.
BMC Proceedings
|
March 1, 2012
Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP
Karlheinz Landauer, Cuneyt Unutmaz, Simon Egli, et al.
JACC. Cardiooncology
|
February 19, 2025
Growth Differentiation Factor-15 Predicts Major Bleeding in Cancer Patients: Results From the Vienna CAT-BLED Study
Cornelia Englisch, Stephan Nopp, Florian Moik, et al.
ANZ Journal of Surgery
|
August 15, 2025
Patterns of Presentation of Prostate Cancer in Patients of Non-English-Speaking Background at an Australian Institution-A 6-Year Retrospective Study
Brendan A Yanada, David Homewood, Vaisnavi Thirugnanasundralingam, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 24, 2025
External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: Results from the RIETE registry
Timothy Hoberstorfer, Stephan Nopp, Daniel Steiner, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 19, 2025
Walking capacity and venous claudication after deep vein thrombosis: prospective follow-up, risk factors, and quality of life
Daniel Steiner, Stephan Nopp, Timothy Hoberstorfer, et al.
Protein Engineering, Design & Selection : PEDS
|
November 1, 2017
Half-life extension using serum albumin-binding DARPin® domains
Daniel Steiner, Frieder W Merz, Ivo Sonderegger, et al.
Journal of Molecular Biology
|
May 1, 2007
A designed ankyrin repeat protein evolved to picomolar affinity to Her2
Christian Zahnd, Emanuel Wyler, Jochen M Schwenk, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Breast Care (Basel, Switzerland)
|
January 27, 2022
Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer Patients
Christoph Suppan, Daniel Steiner, Eva Valentina Klocker, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 15, 2024
Functional limitations 3 and 12 months after venous thromboembolism: a cohort study
Daniel Steiner, Stephan Nopp, Georg Heinze, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 1, 2024
Neoadjuvant therapy in early-stage non-small cell lung cancer: A real-world analysis
Leyla Ay, Daniel Steiner, Hannah Fabikan, et al.
BMC Proceedings
|
March 1, 2012
Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP
Karlheinz Landauer, Cuneyt Unutmaz, Simon Egli, et al.
JACC. Cardiooncology
|
February 19, 2025
Growth Differentiation Factor-15 Predicts Major Bleeding in Cancer Patients: Results From the Vienna CAT-BLED Study
Cornelia Englisch, Stephan Nopp, Florian Moik, et al.
ANZ Journal of Surgery
|
August 15, 2025
Patterns of Presentation of Prostate Cancer in Patients of Non-English-Speaking Background at an Australian Institution-A 6-Year Retrospective Study
Brendan A Yanada, David Homewood, Vaisnavi Thirugnanasundralingam, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 24, 2025
External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: Results from the RIETE registry
Timothy Hoberstorfer, Stephan Nopp, Daniel Steiner, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 19, 2025
Walking capacity and venous claudication after deep vein thrombosis: prospective follow-up, risk factors, and quality of life
Daniel Steiner, Stephan Nopp, Timothy Hoberstorfer, et al.
Protein Engineering, Design & Selection : PEDS
|
November 1, 2017
Half-life extension using serum albumin-binding DARPin® domains
Daniel Steiner, Frieder W Merz, Ivo Sonderegger, et al.
Journal of Molecular Biology
|
May 1, 2007
A designed ankyrin repeat protein evolved to picomolar affinity to Her2
Christian Zahnd, Emanuel Wyler, Jochen M Schwenk, et al.
Page
of 5